Buying Aphria Inc. (APHA) @$3.81

Aphria Inc. is a licensed producer of medical products, growing 100% of its plants in greenhouses. The company sells medical cannabis both online and via phone, and also engages in wholesale shipping of medical marijuana to other licensed producers.

Registered Marijuana sales should hit $146B by 2025.

Clearly, any portfolio should include exposure to this industry. I feel like this is an even bigger opportunity today, given that this stock's price has fallen 90% in the last 18 months.

This company is best in class in the medical Marijuana sector, it's Canada based so no legal issues from the American Fed.